Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according ...
Feb 6, 2024
0
1
Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening program are around four times as likely to develop invasive breast cancer and to die from breast cancer than women in the general ...
Jan 24, 2024
0
7
The overall risk for breast cancer (BC) is increased for women diagnosed with benign breast disease (BBD) in the percutaneous biopsy era compared with the general population, according to a study published online Dec. 13 ...
Dec 13, 2023
0
0
Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according ...
Dec 8, 2023
0
0
A deep learning artificial intelligence (AI) model that was developed using only mammogram image biomarkers has accurately predicted both ductal carcinoma in situ (DCIS) and invasive carcinoma, according to research being ...
Nov 29, 2023
0
26
A new editorial paper titled "Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis" has been published in Oncotarget.
Sep 6, 2023
0
0
A new editorial paper titled "Multiclonality of ER expression in DCIS—Implications for clinical practice and future research" has been published in Oncotarget.
Aug 1, 2023
0
0
A new editorial paper was published in Oncoscience and is titled "HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!"
Feb 17, 2023
0
19
The incidence of a rare cancer, anaplastic large-cell lymphoma (ALCL), has surged in recent years, possibly because of the growing use of textured breast implants. Considering this trend, some breast cancer patients who undergo ...
Dec 2, 2022
0
37
A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.
Nov 18, 2022
0
60
